Protocol No.: I1Q-MC-JDDJ; Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 VersusPlacebo in Older Patents who fell recently and havemuscle weakness. The Study compound is Anti-Myostatin Antibody

Project: Other project

StatusFinished
Effective start/end date4/10/124/10/14

Funding

  • Eli Lilly & Company: $5,468.86